More about

University Of Pennsylvania

News
July 30, 2024
2 min read
Save

Growing armamentarium means ‘we have options’ for ANCA-associated vasculitis

Growing armamentarium means ‘we have options’ for ANCA-associated vasculitis

An growing therapeutic armamentarium for antineutrophil cytoplasmic antibody-associated vasculitis — including avacopan and azathioprine — is providing rheumatologists with an increasingly robust array of options, according to a presenter.

News
July 29, 2024
2 min read
Save

Glucocorticoids ‘not absolutely evil,’ but difficult to taper in giant cell arteritis

Glucocorticoids ‘not absolutely evil,’ but difficult to taper in giant cell arteritis

Glucocorticoids are an effective go-to treatment for giant cell arteritis, but discontinuing them can be difficult, according to a presenter at the 2024 AWIR annual conference.

News
July 23, 2024
4 min read
Save

BLOG: Real leadership is ‘Kindness 101’

BLOG: Real leadership is ‘Kindness 101’

I recently returned from the American Orthopaedic Society for Sports Medicine Annual Meeting in Denver.

News
July 10, 2024
1 min read
Save

Robotic-assisted THA may be associated with less opioid use vs. conventional THA

Robotic-assisted THA may be associated with less opioid use vs. conventional THA

Published results showed robotic-assisted total hip arthroplasty was associated with decreased postoperative opioid use and lower odds of patients developing persistent opioid use compared with conventional THA.

News
June 13, 2024
2 min read
Save

Armored cells may form ‘an effective strategy’ in lymphoma after CAR-T fails

Armored cells may form ‘an effective strategy’ in lymphoma after CAR-T fails

CHICAGO — Treatment of with an investigational chimeric antigen receptor T-cell therapy showed an acceptable safety profile and produced durable remissions among certain patients with non-Hodgin lymphoma.

News
May 15, 2024
4 min read
Save

Researchers hope one-time gene therapy ‘amounts to a cure’ for hemophilia B

Researchers hope one-time gene therapy ‘amounts to a cure’ for hemophilia B

The FDA’s decision to approve a one-time gene therapy for adults with moderate to severe hemophilia B could have a considerable impact on the treatment landscape, according to a researcher involved in the pivotal trial for the agent.

News
May 09, 2024
2 min read
Save

Difficult-to-treat psoriatic arthritis 'not all about the therapies'

Difficult-to-treat psoriatic arthritis 'not all about the therapies'

DESTIN, Fla. — The course of difficult-to-treat psoriatic arthritis can be significantly impacted by a host of factors beyond choice of therapy, according to data presented at the Congress of Clinical Rheumatology East annual meeting.

News
April 24, 2024
3 min read
Save

BLOG: Put first things first

BLOG: Put first things first

I have found the hard way that an essential component of attaining a more fulfilling and peaceful life is to prioritize that which is truly important and execute around those priorities first.

News
April 23, 2024
2 min read
Save

SNOT-22 questionnaire predicts ANCA-associated vasculitis relapse risk up to 2 years

SNOT-22 questionnaire predicts ANCA-associated vasculitis relapse risk up to 2 years

Higher scores on a measure of sinonasal symptoms can predict ANCA-associated vasculitis relapse “months to years” ahead of time, according data published in Arthritis Care & Research.

News
April 03, 2024
4 min read
Save

Training program aims to standardize high-quality oncology patient navigation

Training program aims to standardize high-quality oncology patient navigation

The American Cancer Society launched a national training and credentialing program designed to standardize high-quality, expert patient navigation for individuals with cancer and their caregivers.

View more